Clinical Trial Title A Study in the Treatment of Respiratory Symptoms Associated With Respiratory Syncytial Virus-induced Bronchiolitis in Children Aged Six to 18 Months
Clinical Trial Protocol Description
This 24-week study (eight visits) will examine the effectiveness and safety of two different doses of study drug compared with a placebo.
Clinical Trial Eligibility Criteria
Children between six and 18 months
Diagnosed with bronchiolitis or asthma
Must not be taking theophylline, cromolyn, nedocromil, long-acting beta-agonist, oral cortocosteroids, antileukotriene agents, anticholinergics or ribavarin